Cerebrospinal fluid markers of prion diseases

被引:0
|
作者
Golanska, Ewa [1 ]
Gresner, Sylwia [1 ]
Sieruta, Monika [1 ]
Liberski, Powel [1 ]
机构
[1] Uniwersytet Medyczny Lodzi, Zaklad Patol Mol & Neuropatol, PL-92216 Lodz, Poland
关键词
Creutzfeldt-Jakob disease; 14-3-3; protein; biochemical markers; cerebrospinal fluid; diagnostic tests;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There are no non-invasive tests allowing for definite premortem diagnosis of Creutzfeldt-Jakob disease (CJD). The paper presents the Current knowledge about laboratory tests supporting CJD diagnosis. 14-3-3 protein in the cerebrospinal fluid Is the only biochemical marker included in the diagnostic criteria for CJD approved by WHO. However, the test for 14-3-3 protein is useful Only when considered in an appropriate clinical context, together with other diagnostic criteria. In the paper we also present current research In the use of other proteins detected in the cerebrospinal fluid (tau, S100b, neuron-specific enolase, transthyretin, and beta-amyloid(1-42) as potential diagnostic markers. We discuss advantages and drawbacks of these markers.
引用
收藏
页码:441 / 450
页数:10
相关论文
共 50 条
  • [21] Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases
    Schmitz, Matthias
    Luellmann, Katharina
    Zafar, Saima
    Ebert, Elisabeth
    Wohlhage, Marie
    Oikonomou, Panteleimon
    Schlomm, Markus
    Mitrova, Eva
    Beekes, Michael
    Zerr, Inga
    NEUROBIOLOGY OF AGING, 2014, 35 (05) : 1177 - 1188
  • [22] Imaging of prion diseases
    Letourneau-Guillon, Laurent
    Wada, Ryan
    Kucharczyk, Walter
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2012, 35 (05) : 998 - 1012
  • [23] Cerebrospinal fluid markers for prediction of Alzheimer's disease
    Zetterberg, H
    Wahlund, LO
    Blennow, K
    NEUROSCIENCE LETTERS, 2003, 352 (01) : 67 - 69
  • [24] Cerebrospinal Fluid Total Prion Protein A Potential In Vivo Marker of Cerebral Prion Pathology
    Zetterberg, Henrik
    JAMA NEUROLOGY, 2015, 72 (03) : 261 - 263
  • [25] Neurofilament Light Chain Levels in Serum and Cerebrospinal Fluid Do Not Correlate with Survival Times in Patients with Prion Disease
    Shimamura, Mika
    Weijie, Kong
    Nonaka, Toshiaki
    Kosami, Koki
    Ae, Ryusuke
    Fujita, Koji
    Matsubayashi, Taiki
    Tsukamoto, Tadashi
    Sanjo, Nobuo
    Satoh, Katsuya
    BIOMOLECULES, 2025, 15 (01)
  • [26] CSF biomarkers for prion diseases
    Satoh, Katsuya
    NEUROCHEMISTRY INTERNATIONAL, 2022, 155
  • [27] Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases
    Brettschneider, Johannes
    Widl, Karin
    Ehrenreich, Hannelore
    Riepe, Matthias
    Tumani, Hayrettin
    NEUROSCIENCE LETTERS, 2006, 404 (03) : 347 - 351
  • [28] Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases
    Cramm, Maria
    Schmitz, Matthias
    Karch, Andre
    Zafar, Saima
    Varges, Daniela
    Mitrova, Eva
    Schroeder, Bjoern
    Raeber, Alex
    Kuhn, Franziska
    Zerr, Inga
    MOLECULAR NEUROBIOLOGY, 2015, 51 (01) : 396 - 405
  • [29] Total Prion Protein Levels in the Cerebrospinal Fluid are Reduced in Patients with Various Neurological Disorders
    Meyne, Felix
    Gloeckner, Sara Friederike
    Ciesielczyk, Barbara
    Heinemann, Uta
    Krasnianski, Anna
    Meissner, Bettina
    Zerr, Inga
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (04) : 863 - 873
  • [30] Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry
    Minikel, Eric Vallabh
    Kuhn, Eric
    Cocco, Alexandra R.
    Vallabh, Sonia M.
    Hartigan, Christina R.
    Reidenbach, Andrew G.
    Safar, Jiri G.
    Raymond, Gregory J.
    McCarthy, Michael D.
    O'Keefe, Rhonda
    Llorens, Franc
    Zerr, Inga
    Capellari, Sabina
    Parchi, Piero
    Schreiber, Stuart L.
    Carr, Steven A.
    MOLECULAR & CELLULAR PROTEOMICS, 2019, 18 (12) : 2388 - 2400